+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)
Sangamo Therapeutics Inc - logo

Sangamo BioSciences is a biotechnology company that develops industry leading technologies in gene therapy, genome editing, cell therapy and gene regulation. The company is focused on pioneering genetic cures for monogenic and infectious diseases by deploying its AAV-based gene therapy platform, and therapeutic genome editing and gene regulation platforms based on its novel zinc finger DNA-binding protein technology. Sangamo is headquartered in Richmond, California.

Mucopolysaccharidosis I (Hurler Syndrome) Pipeline Analysis 2018 (H1) - Focusing on Clinical Trials and Results, Drug Profiling, Patents, Collaborations, and Other Recent Developments - Product Thumbnail Image

Mucopolysaccharidosis I (Hurler Syndrome) Pipeline Analysis 2018 (H1) - Focusing on Clinical Trials and Results, Drug Profiling, Patents, Collaborations, and Other Recent Developments

  • Report
  • May 2018
  • 85 Pages
  • Global
From
Global Fabry Disease Drugs Market 2024-2028 - Product Thumbnail Image

Global Fabry Disease Drugs Market 2024-2028

  • Report
  • January 2024
  • 149 Pages
  • Global
From
Hemoglobinopathies - Market Insights, Competitive Landscape, and Market Forecast - 2027 - Product Thumbnail Image

Hemoglobinopathies - Market Insights, Competitive Landscape, and Market Forecast - 2027

  • Report
  • April 2023
  • 100 Pages
  • Global
From
Global Hemoglobinopathies Market (2023-2028) Competitive Analysis, Impact of Economic Slowdown & Impending Recession, Ansoff Analysis - Product Thumbnail Image

Global Hemoglobinopathies Market (2023-2028) Competitive Analysis, Impact of Economic Slowdown & Impending Recession, Ansoff Analysis

  • Report
  • February 2024
  • 179 Pages
  • Global
From
Global Thalassemia Market (2023-2028) Competitive Analysis, Impact of Economic Slowdown & Impending Recession, Ansoff Analysis - Product Thumbnail Image

Global Thalassemia Market (2023-2028) Competitive Analysis, Impact of Economic Slowdown & Impending Recession, Ansoff Analysis

  • Report
  • February 2024
  • 213 Pages
  • Global
From
Hemophilia - Pipeline Insight, 2024 - Product Thumbnail Image

Hemophilia - Pipeline Insight, 2024

  • Drug Pipelines
  • April 2024
  • 250 Pages
  • Global
From
Hemophilia A - Market Insight, Epidemiology And Market Forecast - 2032 - Product Thumbnail Image

Hemophilia A - Market Insight, Epidemiology And Market Forecast - 2032

  • Report
  • September 2022
  • 283 Pages
  • Global
From
Global Sickle Cell Anemia Drug Market, Price, Dosage & Clinical Pipeline Outlook 2024 - Product Thumbnail Image

Global Sickle Cell Anemia Drug Market, Price, Dosage & Clinical Pipeline Outlook 2024

  • Report
  • May 2018
  • 170 Pages
  • Global
From
Global T-Cell (CAR-T, TCR, and TIL) Therapy Market (4th Edition), 2019-2030 - Product Thumbnail Image

Global T-Cell (CAR-T, TCR, and TIL) Therapy Market (4th Edition), 2019-2030

  • Report
  • July 2019
  • 800 Pages
  • Global
From
CAR-T Therapies Market (2nd Edition), 2019-2030 - Product Thumbnail Image

CAR-T Therapies Market (2nd Edition), 2019-2030

  • Report
  • August 2019
  • 580 Pages
  • Global
From
Global CAR T-Cell Therapy Market 2023-2027 - Product Thumbnail Image

Global CAR T-Cell Therapy Market 2023-2027

  • Report
  • May 2023
  • 153 Pages
  • Global
From
Encephalitis Treatment Global Market Report 2024 - Product Thumbnail Image

Encephalitis Treatment Global Market Report 2024

  • Report
  • January 2024
  • 175 Pages
  • Global
From
France CAR-T Cell Therapy Market, By Region, By Competition Forecast & Opportunities, 2018-2028F - Product Thumbnail Image

France CAR-T Cell Therapy Market, By Region, By Competition Forecast & Opportunities, 2018-2028F

  • Report
  • November 2023
  • 90 Pages
  • France
From
Sickle Cell Anemia Drug Global Market Insights 2024, Analysis and Forecast to 2029, by Manufacturers, Regions, Technology, Application - Product Thumbnail Image

Sickle Cell Anemia Drug Global Market Insights 2024, Analysis and Forecast to 2029, by Manufacturers, Regions, Technology, Application

  • Report
  • February 2024
  • 98 Pages
  • Global
From
Hemophilia B Drug Global Market Insights 2024, Analysis and Forecast to 2029, by Manufacturers, Regions, Technology, Application - Product Thumbnail Image

Hemophilia B Drug Global Market Insights 2024, Analysis and Forecast to 2029, by Manufacturers, Regions, Technology, Application

  • Report
  • February 2024
  • 114 Pages
  • Global
From
Hemoglobinopathies Drug Global Market Insights 2024, Analysis and Forecast to 2029, by Manufacturers, Regions, Technology, Application, Product Type - Product Thumbnail Image

Hemoglobinopathies Drug Global Market Insights 2024, Analysis and Forecast to 2029, by Manufacturers, Regions, Technology, Application, Product Type

  • Report
  • January 2024
  • 108 Pages
  • Global
From
United States CAR-T Cell Therapy Market by Product Type, Tumor Type, Indication, Treatment Type, Targeted Antigen, End-user, Region, Competition Forecast & Opportunities, 2028 - Product Thumbnail Image

United States CAR-T Cell Therapy Market by Product Type, Tumor Type, Indication, Treatment Type, Targeted Antigen, End-user, Region, Competition Forecast & Opportunities, 2028

  • Report
  • July 2023
  • 78 Pages
  • United States
From
Global Central Nervous System Therapeutic Market Size, Share & Trends Analysis Report by Disease (Neurovascular Diseases, CNS Trauma, Mental Health, Neurodegenerative Diseases, Infectious Diseases), by Region, and Segment Forecasts, 2021-2028 - Product Thumbnail Image

Global Central Nervous System Therapeutic Market Size, Share & Trends Analysis Report by Disease (Neurovascular Diseases, CNS Trauma, Mental Health, Neurodegenerative Diseases, Infectious Diseases), by Region, and Segment Forecasts, 2021-2028

  • Report
  • February 2021
  • 120 Pages
  • Global
From
Kidney Transplant Rejection - Pipeline Insight, 2024 - Product Thumbnail Image

Kidney Transplant Rejection - Pipeline Insight, 2024

  • Clinical Trials
  • April 2024
  • 50 Pages
  • Global
From
Non-Hodgkin Lymphoma Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players, 2022 Update - Product Thumbnail Image

Non-Hodgkin Lymphoma Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players, 2022 Update

  • Report
  • October 2022
  • 1814 Pages
  • Global
From
Loading Indicator